| Financial Year |
March 31 2023 |
| Monetary Funds |
51,778,207.46 |
| Held-for-trading Financial Assets |
27,334,149.03 |
| Notes Receivable |
15,785,504.42 |
| Accounts Receivable |
248,202,081.09 |
| Advances to Suppliers |
4,205,099.27 |
| Other Receivables |
88,335,299.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
101,922,586.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,047,130.55 |
| Other Current Assets |
6,332,160.84 |
| Total Current Assets |
564,505,923.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
24,798,187.62 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
79,518,804.42 |
| Under-construction Projects |
11,263,644.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,604,724.42 |
| R&D expenses |
-- |
| Goodwill |
4,978,650.13 |
| Long-Term Deferred and Prepaid Expenses |
33,786.80 |
| Deferred Income Tax Assets |
18,109,840.22 |
| Other Non-Current Assets |
7,241,330.44 |
| Sub-Total of Non-Current Assets |
171,544,990.41 |
| Total Assets |
736,050,913.68 |
| Short-Term Loans |
8,708,636.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,780,688.84 |
| Accounts Payable |
45,036,932.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,371,304.00 |
| Taxes Payable |
3,826,417.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
880,895.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
750,037.47 |
| Other Current Liabilities |
2,582,326.00 |
| Sub-Total of Current Liabilities |
115,789,771.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
77,473.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,126,661.35 |
| Total Liabilities |
116,916,433.20 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
175,210,889.39 |
| Surplus Reserve |
33,224,829.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
201,960,046.97 |
| Minority Stockholder's Interest |
8,738,714.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
610,395,765.63 |
| Owner's Equity（Stockholder's Equity） |
619,134,480.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
736,050,913.68 |
